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Abstract: A new proprietary herbomineral formulation was formulated, consisting of essential ingredients viz. herbal root 
extract ashwagandha and minerals (zinc, magnesium, and selenium). The aim of the study was to evaluate the 
immunomodulatory potential of Energy of Consciousness Healing (The Trivedi Effect
®
) Treatment on the herbomineral 
formulation in male Sprague Dawley rats. The test formulation was divided into two parts. One part was denoted as the control 
without Biofield Energy Healing Treatment, while the other part was defined as the Biofield Energy Treated sample, which 
received the Biofield Energy Healing Treatment remotely from seven renowned Biofield Energy Healers. Additionally, one 
group of animals was also received Biofield Energy Treatment per se (day -15) by Biofield Energy Healers under similar 
conditions. The IgM, IgG, CD4
+
, and CD8
+
 were altered in the Biofield Energy Treated test formulation (G4) compared to the 
disease control (G2). TLC was significantly increased by 19.35% in the G4 compared to the G2. Neutrophil was significantly 
increased by 31.53%, 29.73%, 31.53%, and 33.84% in the G4, untreated test formulation (G5), G6, and G7, respectively 
compared to the G2. The levels of total cholesterol (TC), triglycerides (TG), and very low density lipoprotein (VLDL) were 
significantly lowered by 18.18% (p≤0.01), 46.33% (p≤0.01), and 46.41% (p≤0.01), respectively in the G4 compared to the G2. 
Additionally, the levels of TC, TG, low density lipoprotein (LDL), and VLDL were significantly reduced by 25.50% 
(p≤0.001), 96.39% (p≤0.001), 13.91%, and 55.08% (p≤0.001), respectively in the G6 compared to the G2. Alkaline 
phosphatase (ALP) was significantly reduced by 33.65% (p≤0.001) in the G4 compared to the G2. Moreover, the levels of 
serum glutamate oxaloacetate transaminase (SGOT), serum glutamate pyruvate transaminase (SGPT), ALP, and creatine 
kinase myocardium band (CK-MB) were significantly decreased by 29.44% (p≤0.05), 25.54% (p≤0.01), 27.97% (p≤0.01), and 
36.07% (p≤0.01), respectively in the G7 group compared to the G2. Testosterone was significantly increased by 83.68%, 
305.90%, 1271.03% (p<0.001) and 745.35% (p<0.05) in the G4, G5, G6 and G7, respectively compared to the G2. The level 
of catalase enzyme was significantly increased by 57.91% (p<0.01) and 98.51% (p<0.001) in Biofield Energy Treatment per se 
at day -15 (G6) and Biofield Energy Treated test formulation at day -15 (G7), respectively compared to the G2. Overall, results 
suggested that the Biofield Energy Treated herbomineral formulation and Biofield Energy Treatment per se can be used for 
autoimmune and inflammatory diseases, stress management and prevention, and anti-aging by improving overall health. 
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Herbomineral Formulation, Antioxidant, Anti-aging, Inflammatory Disease and Stress Management 
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1. Introduction 
An herbomineral products have been accepted worldwide 
against many health related disorders, due to their significant 
immunomodulatory potential. However, the action of 
herbominerals as an immune booster make it a unique 
compared with other available nutraceutical products. Overall, 
Quality of Life (QoL) can be improved by maintaining the 
organic resistance of the body. It was reported that secondary 
metabolites of plants extract and minerals play an important 
role in the immunomodulatory action [1-3]. An herbal 
medicines and minerals are the major targeted product to 
modulate the immune system due to its low toxicity profile 
compared with the synthetic drugs against infections [4, 5]. 
The main role of existed conventional medicine was to 
diagnose and treat the disease, but in 21
st
 century the primary 
goal of nature-based herbomineral formulation is predictive 
and prevention of diseases. Biomarkers are the biological 
measurements, which can be utilized to predict the severity of 
disease and to recognize the forward detection of disease [6]. It 
was well established that the immune biomarkers were used 
for the early diagnosis and evaluation of target organ damage 
in most of non-autoimmune disease such as diabetes mellitus, 
hypertension, arteriosclerosis etc. [7, 8]. The early diagnosis of 
biomarker is a biologic indicator in clinical practice that 
indicate the risk of specific disorders, its progression, and the 
relative risk/benefit related with the specific therapy, plays a 
central role in the selection of the most effective treatment [9]. 
The new proprietary herbomineral formulation containing four 
ingredients; mixture of minerals (zinc chloride, magnesium 
gluconate hydrate, and sodium selenate) and an herbal extract 
(ashwagandha root extract). Each constituent of this 
formulation is commonly used as nutraceutical supplement 
[10-12]. The immunomodulatory agents have the ability to 
normalize or modulate pathophysiological processes [13, 14]. 
Various studies have reported anti-inflammatory, antiarthritic, 
antibiotic, antitumour immunomodulatory and central nervous 
system effects of withanolides [15, 16]. Zinc plays a major role 
in most of the biochemical reactions in living organism due to 
its enzyme catalyzing activity. Most of the enzymatic reaction 
are zinc dependent. It also plays a key role for regulation of 
sex hormones and in the immune system [17, 18]. Selenium 
also plays a major role for immunomodulation by alterations 
of cluster differentiation (CD8
+
) lymphocyte function [19]. 
Magnesium reduces the production of inflammatory cytokine 
through activation of NF-κB pathways, which is a novel innate 
immunomodulatory mechanism [20]. It is observed that acute 
stress may enhance immune response, whereas chronic stress 
may suppress the immune system [21]. 
Scientific research has been reported that the combination 
of minerals and herbal medicines found to exhibit significant 
immunomodulatory action [22]. An herbomineral 
formulations can be used for better therapeutic effect in 
immune compromised patients that are affected by the 
cardiovascular diseases, age, stress related diseases, cancer, 
and autoimmune disorders. Along with the herbomineral 
formulations, the Biofield Energy Healers in this study have 
used Energy Medicine (Biofield Energy Healing Treatment) 
as a complementary and alternative approach to study the 
impact of Biofield Energy Healing Treatment on the 
herbomineral formulation for its immunomodulatory 
potential in male Sprague Dawley rats. 
Amidst many Complementary and Alternative Medicine 
(CAM) therapies, there have been an extensive number of 
scientific reports that showed Biofield Therapy (or Healing 
Modalities) as preferred models of treatment with several 
benefits to enhance physical, mental and emotional human 
wellness. The National Center of Complementary and 
Integrative Health (NCCIH) has recognized and accepted 
Biofield Energy Healing as a CAM health care approach in 
addition to other therapies, medicines and practices such as 
natural products, deep breathing, yoga, Tai Chi, Qi Gong, 
chiropractic/osteopathic manipulation, meditation, massage, 
special diets, homeopathy, progressive relaxation, guided 
imagery, acupressure, acupuncture, relaxation techniques, 
hypnotherapy, healing touch, movement therapy, pilates, 
rolfing structural integration, mindfulness, Ayurvedic 
medicine, traditional Chinese herbs and medicines, 
naturopathy, essential oils, aromatherapy, Reiki, and cranial 
sacral therapy. Human Biofield Energy has subtle energy that 
has the capacity to work in an effective manner [23]. CAM 
therapies have been practiced worldwide with reported 
clinical benefits in different health disease profiles [24]. 
Biofield Energy Healing Treatment has gained rapid rapport 
as a holistic alternative and complementary medicine therapy 
that has significant impact on living organisms and nonliving 
materials without any adverse effects and in a manner that is 
more cost-effective than more conventional methods. 
Biofield Energy Treatment (The Trivedi Effect
®
) results has 
been published in numerous peer-reviewed science journals 
with significant outcomes in many scientific fields such as 
cancer research [25], microbiology [26-28], genetics [29, 30], 
pharmaceutics [31, 32], nutraceuticals [33], organic 
compounds [34, 35], agricultural science [36, 37], and 
changing the structure of the atom in relation to various 
metals, ceramics, polymers and chemicals in materials 
science [38-40]. In this study, the authors sought to explore 
the impact of the Biofield Energy Treatment (The Trivedi 
Effect
®
) on the given herbomineral formulation and Biofield 
Energy Treatment per se to the animals, which might 
improve the immunomodulatory function in 
cyclophosphamide induced immunosuppression in male 
Sprague Dawley rat model by identification of various 
immunity biomarkers. 
2. Materials and Methods 
2.1. Chemicals and Reagents 
Ashwagandha root extract powder was procured from 
Sanat Products Ltd., India. Zinc chloride and magnesium (II) 
gluconate hydrate were procured from TCI, Japan. Sodium 
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selenate was procured from Alfa Aesar, USA. 
Cyclophosphamide was used as inducing agent for 
immunosuppression was procured from Zydus Oncosciences 
India. Levamisole hydrochloride and sodium carboxymethyl 
cellulose (Na-CMC) were procured from Sigma-Aldrich, 
USA. All other chemicals used were of analytical grade 
available in India. 
2.2. Experimental Animals 
A total number of 56 healthy male Sprague Dawley rats, 
weighing between 220-250 grams, were used for the study 
(n=8, in each group). The animals were purchased from M/s. 
Vivo Bio Tech Ltd., Hyderabad, India. Standard rodent diet 
was procured from M/s. Golden feeds, Mehrauli, New Delhi, 
India and provided ad libitum to all the groups of animals 
during the experiment under controlled conditions with a 
temperature of 22 ± 3°C, humidity of 30% to 70% and a 12-
hour light/12-hour dark cycle. The animals were acclimatized 
for 5 days prior to the experiment, and all were accessed once 
daily for clinical signs, behaviors, morbidity and mortality. 
All the procedures were in strict accordance with the Guide 
for the Care and Use of Laboratory Animals published by the 
US National Institutes of Health. The approval of the 
Institutional Animal Ethics Committee that was obtained 
prior to carrying out the animal experiment. 
2.3. Biofield Energy Treatment Strategies 
The test formulation was divided into two parts. One part 
of the test formulation was treated with the Biofield Energy 
by renowned Biofield Energy Healers (also known as The 
Trivedi Effect
®
) and coded as the Biofield Energy Treated 
formulation, while the second part of the test formulation did 
not receive any sort of treatment and was defined as the 
untreated test formulation. This Biofield Energy Treatment 
was provided through a group of seven Biofield Energy 
Healers who participated in this study and performed the 
Biofield Energy Treatment remotely were located in the 
U.S.A., while the test herbomineral formulation was located 
in the research laboratory of Dabur Research Foundation, 
New Delhi, India. Additionally, one group of animals was 
also received the Biofield Energy Treatment per se by the 
Biofield Energy Healers under similar conditions. This 
Biofield Energy Treatment was administered for 5 minutes 
through the Healer’s unique Energy Transmission process 
remotely to the test formulation under laboratory conditions. 
None of the Biofield Energy Healers in this study visited the 
laboratory in person, nor had any contact with the 
herbomineral samples. Further, the control group was treated 
with a “sham” healer for comparative purpose. The sham 
healer did not have any knowledge about the Biofield Energy 
Treatment. After that, the Biofield Energy Treated and 
untreated samples were kept in similar sealed conditions and 
used for identification of immunological parameters. 
2.4. Antigen (Sheep RBC) 
The fresh sheep blood was collected aseptically from the 
jugular vein of a healthy sheep and transferred immediately 
to the heparinized tube. The collected erythrocytes were 
separated from plasma by centrifugation (400 g, 10 ºC, 10 
minutes), washed twice with the normal saline and then 
further diluted in saline, which were analyzed using 
Hematology analyzer (Abbott Model-CD-3700). Based on 
the number of erythrocytes, the samples were further diluted 
(using saline) before injecting to the rats [41]. 
2.5. Experimental Procedure 
After seven days of acclimatization, the animals were 
grouped based on the body weight. A total of seven groups 
(G) were included i.e. G1 to G7 with eight animals (n=8) in 
each group. The animals were received cyclophosphamide in 
all the groups except G1 at a dose of 10 mg/kg in normal 
saline through intraperitoneal (i.p.) route 1 hour before 
administration of the test formulation, from day 1 to 13. 
However, G1, G2, and G6 group’s animals were administered 
with vehicle (0.5% carboxy methyl cellulose-sodium) via 
oral gavage. The G3 group animals received reference item, 
levamisole at a dose of 75 mg/kg body weight. The G4 group 
animals received Biofield Energy Treated test formulation at 
1105.005 mg/kg b.wt, per-oral (p.o.), and the G5 animals 
received the untreated test formulation at the same dose by 
oral route. Further, the G6 group animals received only 
Biofield Energy Treatment per se at day -15, without test 
formulation, while G7 group animals received Biofield 
Energy Treated test formulation at day -15. The freshly 
prepared suspensions of the Biofield Energy Treated and 
untreated test formulations were administered orally to the 
G4 and G5 groups, respectively at a dose of 1105.005 mg/kg 
from day 1 to day 25. However, Biofield Energy Treated test 
formulation was administered orally to the G7 group at same 
dose from day -15 to day 25. The treatment was continued to 
all the tested groups (G1 to G7) with 5 mL/kg body weight 
dose volume. 
However, all the animals (G1-G7) were challenged with 
sheep red blood cells (sRBC) (0.5 x 10
9
/100 gm; i.p.) on day 
7 and 13, as the antigenic material to sensitize them for 
immunological studies. On day 13
th
 and 20
th
 the animals 
were bled and the samples were subjected to 
hemagglutination test for cellular (CD4
+
 and CD8
+
) and 
humoral (IgG and IgM) immune responses. On same day 
20
th
, the animals were challenged with sRBC (0.5 x 10
9
 
cells/50µL/rat) in sub-planter region and on day 21
st
 (24 
hours) paw volume was measured to evaluate the cellular 
immune response. The body weight and feed consumption 
were measured daily before treatment. The animals were kept 
on overnight fasting on day 24, followed by blood collection 
from retro-orbital plexus under isoflurane anaesthesia and the 
samples were subjected for haematology analysis, serum for 
biochemistry and hormone estimation. A portion of liver 
samples were snap frozen and stored in -80°C for the 
estimation of anti-oxidant parameters (SOD, Catalase, and 
LPO). At the end of the study, animals were euthanized by 
CO2 asphyxiation as per in-house approved standard 
protocol. 
 International Journal of Pharmacy and Chemistry 2017; 3(6): 99-108 102 
 
2.6. Assessment of Cellular and Humoral Responses 
Humoral immune response, IgG and IgM were estimated 
using Mini Vidas, Biomeurix (French) from serum, using 
commercially available kits. Flow cytometry was used to 
evaluate the CD4
+
 and CD8
+
 cells in blood as a measure of 
the cellular immune response. The mean value was 
calculated for each group with SEM. The percent change in 
the Biofield Energy Treated group was calculated compared 
to the vehicle treatment group. 
2.7. Assessment of Hematology Parameters 
Hematological parameters such as total leukocyte count 
(TLC) and differential leukocyte counts (DLC) were 
analyzed using Hematology analyzer (Abbott Model-CD-
3700) in blood samples. 
2.8. Assessment of Lipid Profile and Hepatic Enzymes 
Glucose, total cholesterol (TC), triglycerides (TG), low 
density lipoprotein (LDL), high density lipoprotein (HDL), 
very low density lipoprotein (VLDL), alkaline phosphatase 
(ALP), serum glutamic oxaloacetic transaminase (SGOT), 
and serum glutamate-pyruvate transaminase (SGPT) were 
analyzed using serum [42, 43]. 
2.9. Assessment of Sex Hormone 
Testosterone was analyzed in serum using commercial kits. 
The mean value was calculated for each group with SEM. 
The percent change in the Biofield Energy Treated group was 
calculated compared to the vehicle treatment group. 
 
2.10. Assessment of Antioxidant Profile by ELISA Assay 
Superoxide dismutase (SOD), catalase and lipid 
peroxidation (LPO) were analysed by ELISA assay using 
liver homogenate sample [44-46]. 
2.11. Statistical Analysis 
The data were expressed as mean ± standard error of mean 
(SEM) and subjected to statistical analysis using SigmaPlot 
(Version 11.0). Student’s t-test was performed for comparison 
of the individual treatment group with control. The p≤0.05 
was considered as statistically significant. 
3. Results and Discussion 
3.1. Measurement of Humoral Immune Response 
The effects of Biofield Energy Treated and untreated test 
formulation on the levels of IgM and IgG in male SD rats are 
shown in the Figure 1. The animals administered with 
untreated test formulation (G5) showed 14.27% increase in 
IgG compared to the G2 group; while it was altered in the 
rest of the tested groups. The level of IgM was reduced by 
13.07%, 3.92% and 16.34% in the Biofield Energy Treated 
test formulation (G4), Biofield Energy Treatment per se at 
day -15 (G6) and Biofield Energy Treated test formulation at 
day -15 (G7), respectively compared to the G2 group. 
Yamada et al. [47], had reported that ashwagandha to 
enhance the immune function by increasing immunoglobulin 
production. In this experiment the Biofield Energy Treated 
test formulation showed slight increase the level of IgG 
compared to the disease control group. The data was 
supported with the literature [47, 48]. 
 
Figure 1. The effect of the test formulation on immunoglobulins (A. IgM and B. IgG) after 24 consecutive days of treatment in male SD rats. G1: Normal 
control; G2: Disease control; G3: Levamisole; G4: Biofield Energy Treated test formulation; G5: Untreated test formulation; G6: Biofield Energy Treatment 
per se at day -15; and G7: Biofield Energy Treated test formulation at day -15. All the values are represented as mean ± SEM (n=8). 
3.2. Measurement of Cellular Responses 
The effect of the test formulation on the levels of CD4
+
 and CD8
+
 in male SD rats is depicted in the Figure 2. The CD 
markers such as percentage of CD4
+
 and CD8
+
 cells were analyzed using whole blood. No substantial changes of CD4
+
 counts 
were observed across the groups, while the CD8
+
 count was increased by 7.17% and 1.42% in the untreated test formulation 
(G5) and Biofield Energy Treatment per se (G6) respectively, compared to the disease control (G2). 
0
0.05
0.1
0.15
0.2
0.25
G1 G2 G3 G4 G5 G6 G7
m
g
/m
L
A. IgM
2
2.5
3
G1 G2 G3 G4 G5 G6 G7
m
g
/m
L
B. IgG
103 Mahendra Kumar Trivedi et al.:  Evaluation of the Effects of Biofield Energy Healing Based Herbomineral Formulation   
on Various Biomarkers in Male Sprague Dawley Rats: Potential Role of the Trivedi Effect® 
 
Figure 2. The effect of the test formulation on immunoglobulin cellular biomarkers (A. CD4+ and B. CD8+) after 24 consecutive days of treatment in male SD 
rats. All the values are represented as mean ± SEM (n=8). 
3.3. Assessment of Hematology Parameters 
The hematology parameters such as total and differential 
leucocytes counts are shown in the Table 1. The disease 
control group (G2) showed immunosuppression response was 
induced by cyclophosphamide as evident with the significant 
reduction of TLC, lymphocytes, and eosinophils by 29.43%, 
14.23%, and 14.29%, respectively compared to the normal 
control group (G1). The TLC was increased by 19.35% and 
2.25% in the Biofield Energy Treated test formulation (G4) 
and Biofield Energy Treated test formulation at day -15 (G7), 
respectively compared to the disease control (G2). The level 
of neutrophils was significantly increased by 31.53%, 
29.73%, 31.53%, and 33.84% in the Biofield Energy Treated 
test formulation (G4), untreated test formulation (G5), 
Biofield Energy Treatment per se (G6) at day -15, and 
Biofield Energy Treated test formulation at day -15 (G7), 
respectively compared to the disease control group (G2). The 
level of lymphocytes was reduced minimally in all the treated 
groups (G3 - G7) compared to the disease control (G2). The 
eosinophils level was increased by 8.67%, 8.67%, 16.67%, 
and 14% in the Biofield Energy Treated test formulation 
(G4), untreated test formulation (G5), Biofield Energy 
Treated group per se (G6), and Biofield Energy Treated test 
formulation at day -15 (G7), respectively compared to the 
disease control (G2). The level of monocytes was decreased 
by 39.95% in the G4, G5, and G6; while increased by 8.68% 
in the Biofield Energy Treated test formulation group at day -
15 (G7) compared to the disease control (G2). The positive 
control levamisole showed 26.13% and 16.67% increase in 
the levels of neutrophils and eosinophils, respectively 
compared to the disease control (G2). Eosinophils play the 
role of a beneficial modulatory element or an innocent 
bystander. Jung et al. [49], demonstrated that an increasing 
number of experimental observations indicated that 
eosinophils have multifunctional leukocytes that are involved 
in diverse inflammatory and physiologic immune responses. 
They have found the potential role of eosinophils as a 
modulators of the intestinal immune system [40]. This study 
therefore demonstrated that the Biofield Energy Treated test 
formulation (G4) showed an enhancement of the level of 
eosinophil to some extent compared to the G2 group. 
Another researcher reported the eosinophils and neutrophils 
show in the protective innate immune response [50]. Besides, 
the level of neutrophil was significantly increased by 31.53% 
in the G4 group compared to the G2 group. 
Table 1. Effect of the test formulation on hematological parameters. 
Group TLC (103/mm3) Neutrophils (%) Lymphocytes (%) Eosinophils (%) Monocyte (%) 
G1 11.35 ± 1.01 17.88 ± 2.27 77.38 ± 2.93 1.75 ± 0.49 3.00 ± 0.89 
G2 8.01 ± 1.09 27.75 ± 3.27 66.38 ± 4.03 1.50 ± 0.19 4.38 ± 1.13 
G3 7.25 ± 0.52 35.00 ± 4.67 59.63 ± 5.03 1.75 ± 0.25 3.63 ± 0.50 
G4 9.56 ± 1.29 36.50 ± 4.18 59.25 ± 4.17 1.63 ± 0.18 2.63 ± 0.18 
G5 6.21 ± 0.72 36.00 ± 2.18 59.75 ± 2.23 1.63 ± 0.18 2.63 ± 0.18 
G6 6.21 ± 0.66 36.50 ± 1.94 59.13 ± 2.00 1.75 ± 0.25 2.63 ± 0.26 
G7 8.19 ± 0.62 37.14 ± 3.25 57.14 ± 3.40 1.71 ± 0.42 4.00 ± 0.98 
Analysis of hematological profile like total and differential (5 parts) counts of white blood corpuscles after consecutive 24 days of treatment of the test 
formulation in male SD rats. All the values are represented as mean ± SEM (n=8). G: Group; G1: Normal control; G2: Disease control; G3: Levamisole; G4: 
Biofield Energy Treated test formulation; G5: Untreated test formulation; G6: Biofield Energy Treatment per se at day -15; and G7: Biofield Energy Treated 
test formulation at day -15. TLC: Total leukocyte count; %: Percentage 
3.4. Measurement of Glucose and Lipid Biomarkers 
The biochemical parameters i.e. glucose, lipid profile such 
as total cholesterol (TC), triglycerides (TG), high density 
lipoprotein (HDL), low density lipoprotein (LDL), and very 
low density lipoprotein (VLDL) are shown in the Table 2. 
The disease control group (G2) showed an increased level of 
LDL by 2.27% compared to the normal control group (G1). 
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The levels of TC, TG, LDL, and VLDL were significantly 
reduced by 19.34% (p≤0.01), 21.94%, 20.85% (p≤0.01), and 
22.15%, respectively in the Biofield Energy Treated test 
formulation group (G4) compared to the disease control 
(G2). Besides, the levels of TC, TG, LDL, and VLDL were 
remarkably reduced by 18.18% (p≤0.01), 46.33% (p≤0.01), 
7.05%, and 46.41% (p≤0.01), respectively in the untreated 
test formulation group (G5) compared to the disease control 
(G2). Moreover, the levels of TC, TG, LDL, and VLDL were 
significantly reduced by 25.50% (p≤0.001), 96.39% 
(p≤0.001), 13.91%, and 55.08% (p≤0.001), respectively in 
the Biofield Energy Treated test formulation at day -15 (G7) 
compared to the disease control (G2). The positive control 
levamisole showed 17.84%, 8.09%, 21.89%, and 7.63% 
increased the levels of TC, TG, LDL, and VLDL, 
respectively compared to the disease control (G2). The levels 
of HDL and glucose were altered in all the tested groups 
compared to the disease control (G2). 
Table 2. Effect of the test formulation on lipid biomarkers. 
Group Glucose (mg/dL) Total Cholesterol (mg/dL) Triglyceride (mg/dL) HDL (mg/dL) LDL (mg/dL) VLDL (mg/dL) 
G1 126.63 ± 8.07 91.48 ± 4.75 102.96 ± 6.62 27.39 ± 1.43 43.49 ± 3.66 20.57 ± 1.32 
G2 117.06 ± 6.03 89.40 ± 3.80 87.10 ± 11.03 26.78 ± 1.14 45.08 ± 1.99 17.43 ± 2.21 
G3 154.61 ± 23.44 105.35 ± 5.26 94.15 ± 4.18 31.58 ± 1.58 54.95 ± 3.58 18.76 ± 0.80 
G4 147.10 ± 10.57 72.11 ± 2.98** 67.99 ± 8.52 21.62 ± 0.89 35.68 ± 1.64** 13.57 ± 1.70 
G5 124.74 ± 10.43 73.15 ± 3.92** 46.75 ± 4.85** 21.91 ± 1.18 41.90 ± 2.17 9.34 ± 0.97** 
G6 203.23 ± 22.16 86.48 ± 3.75 88.81 ± 22.15 25.90 ± 1.12 42.73 ± 3.11 17.77 ± 4.43 
G7 127.73 ± 8.83 66.60 ± 3.69*** 39.14 ± 4.31*** 19.94 ± 1.11 38.81 ± 2.33 7.83 ± 0.86*** 
Analysis of lipid profile after consecutive 24 days of treatment of the test formulation in male SD rats. All the values are represented as mean ± SEM (n=8). 
Group; G1: Normal control; G2: Disease control; G3: Levamisole; G4: Biofield Energy Treated test formulation; G5: Untreated test formulation; G6: Biofield 
Energy Treatment per se at day -15; and G7: Biofield Energy Treated test formulation at day -15. HDL: High density lipoprotein; LDL: Low density 
lipoprotein; VLDL: Very low density lipoprotein; mg/dL: Milligram per deciliter; **p≤0.01 and ***p≤0.001 (compared to the disease control). 
3.5. Measurement of Hepatic and Cardiac Biomarkers 
The effect of the test formulation on the hepatic and 
cardiac biomarkers are shown in the Table 3. The level of 
ALP was significantly reduced by 33.65% (p≤0.001) in the 
Biofield Energy Treated test formulation group (G4) 
compared to the disease control (G2). The SGOT, ALP, and 
CK-MB were significantly decreased by 10.74%, 29.85% 
(p≤0.05), and 15.32%, respectively in the Biofield Energy 
Treatment per se at day -15 (G6) compared to the G2 group. 
Moreover, the levels of SGOT, SGPT, ALP, and CK-MB 
were significantly decreased by 29.44% (p≤0.05), 25.54% 
(p≤0.01), 27.97% (p≤0.01), and 36.07% (p≤0.01), 
respectively in the Biofield Energy Treated test formulation 
at day -15 (G7) compared to the G2 group. The ratio of A/G 
was reduced minimally in the levamisole group (G3) 
compared to the G2 group. Rest of the biochemical 
parameters like total bilirubin, total protein, albumin, and 
globulin did not show any significant changes in all the tested 
groups compared to the G2 group. Alteration of immune 
functions are associated with the elevation of liver enzymes 
in various disorders. The Biofield Energy Treated test 
formulation group (G4) showed decreased level of ALP by 
33.65% compared to the G2 group, which would be 
beneficial in immunodeficiency patients. Thus, it is assumed 
that the reduction of ALP might be due to the effect of the 
Biofield Energy Healing Treatment to the test formulation. It 
had been shown that ashwagandha reduced the level of ALP 
level in rats. The current data were also corroborated with the 
reported literature [51]. 
Table 3. Effect of the test formulation on hepatic and cardiac biomarkers in male rats. 
Group SGOT (U/L) SGPT (U/L) ALP (U/L) CK-MB (U/L) 
Tot. BL 
(mg/dL) 
Tot. Prot. 
(g/dL) 
A (g/dL) G (g/dL) A/G ratio 
G1 201.68 ± 13.31 48.91 ± 3.79 306.88 ± 28.44 828.19 ± 82.35 0.13 ± 0.01 8.17 ± 0.06 3.82 ± 0.03 4.35 ± 0.05 0.88 ± 0.01 
G2 170.58 ± 10.68 42.79 ± 3.15 305.05 ± 21.10 825.93 ± 61.10 0.14 ± 0.01 7.81 ± 0.17 3.78 ± 0.03 4.03 ± 0.16 0.95 ± 0.04 
G3 164.26 ± 10.57 52.31 ± 1.73 243.66 ± 9.83* 719.13 ± 73.17 0.14 ± 0.01 8.06 ± 0.23 3.73 ± 0.06 4.96 ± 0.58 0.80 ± 0.06 
G4 197.01 ± 27.31 44.44 ± 6.93 202.41 ± 14.16*** 969.43 ± 86.79 0.15 ± 0.02 7.62 ± 0.15 3.70 ± 0.04 3.92 ± 0.13 0.95 ± 0.03 
G5 178.90 ± 9.87 38.42 ± 1.65 209.50 ± 19.20** 809.99 ± 65.30 0.11 ± 0.00 7.72 ± 0.16 3.71 ± 0.07 4.01 ± 0.19 0.94 ± 0.05 
G6 152.26 ± 9.94 44.70 ± 2.06 213.98 ± 24.93* 699.43 ± 109.63 0.13 ± 0.01 8.13 ± 0.16 3.73 ± 0.05 4.40 ± 0.12 0.85 ± 0.02 
G7 120.36 ± 8.69** 31.86 ± 2.97* 219.74 ± 6.26** 528.01 ± 73.26** 0.14 ± 0.01 7.44 ± 0.12 3.71 ± 0.05 3.76 ± 0.07 0.99 ± 0.01 
Analysis of the hepatic and cardiac biomarkers after consecutive 24 days of treatment of the test formulation in male SD rats. All the values are represented as 
mean ± SEM (n=8). Group; G1: Normal control; G2: Disease control; G3: Levamisole; G4: Biofield Energy Treated test formulation; G5: Untreated test 
formulation; G6: Biofield Energy Treatment per se at day -15; and G7: Biofield Energy Treated test formulation at day -15. SGOT: Serum glutamic 
oxaloacetic transaminase; SGPT: Serum glutamate-pyruvate transaminase; ALP: Alkaline phosphatase; CK-MB: Creatine kinase-myocardial band; Tot. BL: 
Total bilirubin; Tot. Prot.: Total protein; A: Albumin; G: Globulin; A/G: Albumin/Globulin ratio; U/L: Unit per liter; mg/dL: Milligram per deciliter; *p≤0.05, 
**p≤0.01, and ***p≤0.001 denoted as statistically significant as compared to the disease control. 
3.6. Measurement of Sex Hormone 
The effect of the test formulation on testosterone is shown 
in the Figure 3. An increasing trend of the testosterone was 
observed across the tested groups compared to the disease 
control (G2). The level of testosterone was significantly 
increased by 83.68%, 305.98%, 1271.03% (p<0.001) and 
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745.35% (p<0.05), in the G4, G5, G6, and G7, respectively 
compared to the G2 group. Ashwagandha (Withania 
somnifera) has been described in traditional Indian Ayurvedic 
medicine as an aphrodisiac that can be used to treat male 
sexual dysfunction and infertility. From the scientific 
literature it was evidenced that ashwagandha root extract has 
increased in sperm concentration, ejaculate volume, and 
motile sperm count and an increase the serum level of 
testosterone [52]. Cinar et al. [53], reported that the 
supplementation of magnesium had increased the both free 
and total testosterone level. Garcia et al. [54], reported that 
zinc protected male sexual organ and simultaneously 
increased the level of serum testosterone in smoked in male 
rats which was due to due to antioxidant and stimulant effects 
of zinc. Researcher had found an ameliorative potential of 
sodium selenate and zinc sulfate on intensive-swimming-
induced testicular disorders, and significantly reduced the 
plasma level of testosterone in mature male rats [55]. 
 
Figure 3. The effect of the test formulation on testosterone after consecutive 24 days of treatment in male SD rats. G1: Normal control; G2: Disease control; 
G3: Levamisole; G4: Biofield Energy Treated test formulation; G5: Untreated test formulation; G6: Biofield Energy Treatment per se at day -15; and G7: 
Biofield Energy Treated test formulation at day -15. All the values are represented as mean ± SEM (n=8), *p≤0.05 and **p≤0.01 (compared to the disease 
control). 
3.7. Measurement of Antioxidant Profile by ELISA 
The effect of the test formulation on various antioxidant 
enzymes like SOD, LPO, and CAT in male SD rats is 
demonstrated in the Figure 4. The level of LPO was 
significantly reduced by 11.98% and 24.15% in the Biofield 
Energy Treatment per se at day -15 (G6) and Biofield Energy 
Treated test formulation at day -15 (G7), respectively 
compared to the disease control (G2). No positive trend was 
observed in case of SOD. The level of CAT enzyme was 
significantly increased by 57.91% (p<0.01) and 98.51% 
p<0.001) in the G6 and G7, respectively compared to the 
disease control Group (G2). 
 
Figure 4. The effect of the test formulation on anti-oxidative markers (A. CAT, B. SOD, and C. LPO) after 24 consecutive days of treatment in male SD rats. 
All the values are represented as mean ± SEM (n=8); **p<0.01 and ***p<0.001 (compared to the disease control). 
4. Conclusions 
Based on the current study findings, the IgM level was 
significantly increased by 13.07% and 16.34% in the Biofield 
Energy Treated test formulation (G4) and Biofield Energy 
Treated test formulation at day -15 (G7), respectively 
compared to the disease control group (G2). The expression 
of the cellular biomarkers like CD4
+
 and CD8
+ 
was altered 
minimally in the Biofield Energy Treated test formulation 
group compared to the disease control. The Biofield Energy 
Treated test formulation group (G4) showed significant 
increase the levels of TLC (19.35%) and neutrophils 
(31.53%), and reduce the levels of lipid biomarkers like TC, 
TG, and VLDL by 18.18%, 46.33%, and 46.41%, 
respectively compared to the disease control group (G2). 
Moreover, the levels of SGOT, SGPT, ALP, and CK-MB 
were significantly decreased by 29.44%, 25.54%, 27.97%, 
and 36.07%, respectively in the G7 group compared to the 
G2 group. The level of the hepatic enzyme like ALP was 
significantly reduced by 33.65% in the G4 group compared 
to the G2 group. Further, testosterone was significantly 
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increased by 83.68% and 745.35% in the G4 and G7, 
respectively compared to the G2 group. The level of catalase 
was significantly increased by 57.91% and 98.51% in the 
Biofield Energy Treatment group per se at day -15 (G6) and 
G7, respectively compared to the G2 group. 
Overall, it can be concluded that the novel herbomineral 
formulation and animals per se after treatment with the 
Trivedi Effect
®
-Biofield Energy Healing remotely by the 
seven Biofield Energy Healers enhanced the herbomineral 
test formulation’s anti-inflammatory and immunomodulatory 
properties. Therefore, the Biofield Energy Treated test 
formulation and animals per se may act as an effective anti-
inflammatory and immunomodulatory product, and it can be 
used as a Complementary and Alternative Medicine (CAM) 
with a safe therapeutic index for various autoimmune 
disorders such as Lupus, Systemic Lupus Erythematosus, 
Fibromyalgia, Addison Disease, Hashimoto Thyroiditis, 
Celiac Disease (gluten-sensitive enteropathy), Multiple 
Sclerosis, Dermatomyositis, Graves’ Disease, Myasthenia 
Gravis, Pernicious Anemia, Aplastic Anemia, Scleroderma, 
Psoriasis, Rheumatoid Arthritis, Reactive Arthritis, Type 1 
Diabetes, Sjogren Syndrome, Crohn’s Disease, Vasculitis, 
Vitiligo, Chronic Fatigue Syndrome and Alopecia Areata, as 
well as inflammatory disorders such as Irritable Bowel 
Syndrome (IBS), Asthma, Ulcerative Colitis, Alzheimer’s 
Disease, Parkinson’s Disease, Atherosclerosis, Dermatitis, 
Hepatitis, and Diverticulitis. Further, the Biofield Energy 
Healing Treated test formulation can also be used in the 
prevention of immune-mediated tissue damage in cases of 
organ transplants (for example heart transplants, kidney 
transplants, and liver transplants), for anti-aging, stress 
prevention and management, and in the improvement of 
overall health and Quality of Life (QoL). 
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